US stocks slide as investors assess jobs data and new earnings
18 Aug 2023 - Stocks slid for a third session on Thursday as investors digested the latest round of earnings and economic data.
18 Aug 2023 - Stocks slid for a third session on Thursday as investors digested the latest round of earnings and economic data.
17 Aug 2023 - A snapshot of the stocks on the move, featuring Summit Minerals (ASX:SUM), American West Metals (ASX:AW1), Lithium Universe (ASX:LU7) and Aldoro Resources (ASX:ARN).
17 Aug 2023 - Stocks fell Wednesday as investors digested a summary of the Federal Reserve’s July meeting, which hinted at potentially higher rates.
16 Aug 2023 - A snapshot of the stocks on the move, featuring AML3D (ASX:AL3), Imugene (ASX:IMU) and Loyal Lithium (ASX:LLI).
16 Aug 2023 - Dr John Melki - CEO and Director - Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
16 Aug 2023 - Sam Budiselik - Managing Director - Cash Converters (ASX:CCV) is a diverse group generating revenues from franchising, store operations, personal and vehicle finance.
16 Aug 2023 - Steven Yatomi Clarke - CEO and Managing Director - Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
16 Aug 2023 - Yoav Amitai - CEO - Elsight's (ASX:ELS) Halo provides connectivity and delivers absolute connection confidence for drones and other unmanned systems.
16 Aug 2023 - Mark Leong - Executive Chairman - Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
16 Aug 2023 - Tom Spurling - Executive Director - Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.